EDITORIAL BOARD MEMBERS
Department of Pharmacology and Experimental Neuroscience
Univeristy of Nebraska
United States
BIOGRAPHY:
Dr. Xinming Liu is an Assistant Professor in the Department of Pharmacology and Experimental Neuroscience, College of Medicine, and a courtesy faculty in the Department of Pharmaceutical Sciences, College of Pharmacy, at the University of Nebraska Medical Center (UNMC). Dr. Lius research mainly focuses on the development and evaluation of drug delivery systems, nanomedicine and small molecule prodrugs for treatment of human diseases. His research is highly technology- and science-driven, with strong translational emphasis on targeted therapy of HIV/AIDS, inflammatory diseases and orofacial diseases. Dr. Lius research results in 15 US and worldwide patents (e.g. WO, US, AU, CA, CN, EP, JP, KR), 3 licensed technologies and 2 start-up pharmaceutical companies. In addition to his multiple technological accomplishments, Dr. Liu excels in scholarship as documented by 39 peer-reviewed publications in leading drug delivery journals, including Biomaterials, Nanomedicine, and Journal of Controlled Release. Dr. Liu presented his research at various professional meetings (AAPS, CRS, IADR, NanoDDS, ASBMR, SNIP) as an active member. Dr. Liu is also very active in academic services, and is serving for more than 10 leading peer-reviewed scientific journals as a regular reviewer or editorial board member. In recognition of Dr. Lius achievements, he was awarded the 2007 American Society for Bone and Mineral Research Young Investigator Award, 2007 CRS Innovative Aspects of Oral Drug Delivery & Absorption Award, 2009 UNMC Postdoctoral Scholar Award, 2010 UNeMed Research Innovation Award, and 2012 Nebraska N. Badami Distinguished Scientist Award.
Dr. Lius research interests mainly focus on chemically engineering novel biomaterials, drug delivery systems (DDS), nanomedicine, and low-molecular-weight prodrugs for the targeting theranostic application of HIV, CNS diseases, cancer, inflammatory diseases, and orofacial diseases. Specific areas include: Nanoformulated antiretroviral therapeutics (NanoART) for the targeted and long-acting therapy of HIV/AIDS. Liposomes, micelles and solid lipid nanoparticles (SLN) for CNS, inflammatory, and orofacial diseases. Ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles for the targeting theranostic application of Cancer and CNS diseases. Polymer therapeutics for CNS diseases, cancer, inflammatory diseases and orofacial diseases. Novel targeting Prodrug design.
OTHER EDITORIAL BOARD MEMBER
Laboratory of Environmental & Energy Nanomaterials (NANOEE)
College of Environmental Science and Engineering
Tongji University
China
Nanoscience Technology Center
University of Central Florida
United States
Associate Vice President of Global Medical Development
Associate Dean of International Research
University of South Florida (USF)
United States
Department of Chemical and Biological Engineering
University of Northwestern
United States
Nano/Micro-Systems Research Laboratory
University of Waterloo
Canada
Department of Cell Biology
University of Kent
United Kingdom
UCL Healthcare Biomagnetic and Nanomaterials Laboratories
Univeristy College London
United Kingdom
Project Center for Nanotechnology and Advanced Engineering
NCSR Demokritos
Greece
Laboratory for the Synthesis of New Materials
Division of Materials Chemistry
Ruder Boskovic Institute
Croatia
George W. Woodruff School of Mechanical Engineering
Georgia Institute of Technology
United States
Department of Mechanical Engineering
The University of Texas
United States
Institute of Functional Nano & Soft Materials
Soochow University
China
Suzhou Institute of Nano-Tech and Nano-Bionics
Chinese Academy of Sciences
China
School of Materials Science and Engineering
Shanghai Jiaotong University
China
Division of Nanobiomedicine
Suzhou Institute of Nano-Tech and Nano-Bionics
Chinese Academy of Sciences
China
School of Materials Science and Engineering
Shanghai Jiao Tong University
China
Laboratory for Biological Effects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology
China
School of Microelectronics and Solid-State Electronics
University of Electronic Science and Technology of China
China
Pushpagiri Institute of Medical Sciences and Research Centre
India
Department of Applied Physics
University Complutense of Madrid
Spain
Department of Food Toxicology & Contaminants
National Research center
Egypt
Department of Chemical and Materials Engineering
Chang Gung University
Taiwan
National Instiute of Applied Science and Technology
Tunisia
Department of Plasma Physics
Alliance University
India
MD Anderson Cancer Center
The University of Texas
United States
U.S. Photovoltaic Manufacturing Consortium
State University of New York
United States
National Institute for Nanotechnology
University of Alberta
Canada
Department of Pharmaceutics
Tabriz University of Medical Sciences
Iran
Pusan National University
South Korea
Department of Electronics and Communication Engineering
SVS College of Engineering
India
Centre for Material Science Advanced Research in Nanoscience and Nanotechnology
KLE Technological University
India
